American Association for Cancer Research (AACR) Annual Meeting
DATE31/03/2012 - 05/04/2012
PLACEChicago U.S.A.
Correlation between BRCA1 and LMO4 mRNA expression levels in erlotinib- treated NSCLC patients with EGFR mutations Costa C, PhD
Mutations in p53 are associated with shorter time to progression (TTP) and overall survival (OS) in erlotinib-treated, EGFR-mutated patients Molina M.D, PhD